Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2010
Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom controlMichael Schatz, Eli O Meltzer, Robert Nathan, et al.
Allergy and Asthma Proceedings|January 17, 2003
No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one yearDavid B Allen, Eli O Meltzer, Robert F Lemanske, et al.
Allergy and Asthma Proceedings|February 20, 2010
Comparative effect of body mass index on response to asthma controller therapyE Rand Sutherland, Carlos A Camargo, William W Busse, et al.
Allergy and Asthma Proceedings|September 18, 2012
Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveysEli O Meltzer, Michael S Blaiss, Robert M Naclerio, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2018
Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure ChamberJean Bousquet, Eli O Meltzer, Peter Couroux, et al.
The Patient|January 26, 2012
Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom ControlRobert A Nathan, Anand A Dalal, Richard H Stanford, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Definition of Nonallergic Rhinopathy, Previously Referred to as Vasomotor Rhinitis, Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael Benninger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 31, 2006
Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivityWilliam W Busse, Thomas B Casale, Mark S Dykewicz, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthmaJonathan Corren, William Busse, Eli O Meltzer, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael S Benninger, et al.
Pageof 15